Surgical procedure in patients with ovarian cancer diagnosed at the time of prophylactic oophorectomy: Analysis of two cases, literature review and surgical implications

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 113, Issue 2, 2004, Pages 251-254

  Morice, P ^a   Pautier, P ^a   Delaloge, S ^a   Spatz, A ^a   Chompret, A ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Nodal involvement; Ovarian cancer; Para aortric lymphadenectomy; Prophylactic oophorectomy

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; PACLITAXEL; PLATINUM;

ADULT; ANAMNESIS; CANCER DIAGNOSIS; CANCER STAGING; CASE REPORT; CLINICAL EXAMINATION; DIAGNOSTIC PROCEDURE; FEMALE; GYNECOLOGICAL EXAMINATION; HUMAN; HUMAN TISSUE; METASTASIS; OVARIECTOMY; OVARY ADENOCARCINOMA; OVARY CANCER; PERITONEAL BIOPSY; PRIORITY JOURNAL; REVIEW;

EID: 1842611100     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2003.09.015     Document Type: Article

References (12)

1. Rebbeck T.R., Lynch H.T., Neuhausen S.L., Narod S.A., Veer L.V., Garber J.E.et al. The prevention and observation of Surgical End Points Study Group: prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N. Eng. J. Med. 346:2002;1616-1622.
2. Leeper K., Garcia R., Swisher E., Goff B., Greer B., Paley P. Pathologic findings in prophylactic oophorectomy specimens in high-risk women. Gynecol. Oncol. 87:2002;52-56.
3. Morice P., Pautier P., Mercier S., Spatz A., Lhommé C., Duvillard P.et al. Laparoscopic prophylactic oophorectomies in women with inherited risk of ovarian cancer. Eur. J. Gynaecol. Oncol. 20:1999;202-204.
4. Salazar H., Godwin A.K., Daly M.B., Laub P.B., Hogan W.M., Rosenblum N. et al. Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies. J. Natl. Cancer Inst. 88:1996;1810-1820.
5. Johannssonn O.T., Ranstam J., Olsson H. Survival of BRCA1 breast and ovarian cancer patients: a population based study from southern Sweden. J. Clin. Oncol. 16:1998;397-404.
6. Stratton J.F., Buckley C.H., Lowe D., Ponder B.A.J. The United Kingdom Coordinating Committee on Cancer Research Familial Ovarian Cancer Study Group: comparison of prophylactic oophorectomies specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation. J. Natl. Cancer Inst. 91:1999;626-628.
7. Lu K.H., Garber J.E., Cramer D.W., Welch W.R., Niloff J., Schrag D., Berkowitz R.S., Muto M.G. Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy. J. Clin. Oncol. 18:2000;2728-2732.
8. Colgan T.J., Murphy J., Cole D.E.C., Narod S., Rosen B. Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status. Am. J. Surg. Pathol. 25:2001;1283-1289.
9. Agoff S.N., Mendelin J.E., Grieco V.S., Garcia R.L. Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or -2 mutations. Am. J. Surg. Pathol. 26:2002;171-178.
10. Scheuer L., Kauff N., Robson M., Kelly B., Barakat R., Satagopan J.et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J. Clin. Oncol. 20:2002;1260-1268.
11. Ben David Y., Chetrit A., Hirsh-Yechezkel G., Friedman E., Beck B.D., Beller U.et al. The National Israeli Study of ovarian cancer: effect of BRCA mutations on the length of survival in epithelial ovarian tumors. J. Clin. Oncol. 20:2002;436-463.
12. Cass I., Baldwin R.L., Varkey T., Moleshi R., Narod S., Karlan B.Y. Improved survival in women with BRCA-associated ovarian carcinoma. Cancer. 97:2003;2187-2195.